期刊簡介 | |||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名稱 | ANNALS OF THE RHEUMATIC DISEASES LetPub Score 9.6
50 ratings
Rate
Reputation 9.9 Influence 9.3 Speed 9.7 | ||||||||||||||||||||||||||||
期刊簡稱 | ANN RHEUM DIS | ||||||||||||||||||||||||||||
ISSN | 0003-4967 | ||||||||||||||||||||||||||||
E-ISSN | 1468-2060 | ||||||||||||||||||||||||||||
h-index | 212 | ||||||||||||||||||||||||||||
CiteScore |
| ||||||||||||||||||||||||||||
自引率 (2023-2024) | 7.40%自引率趨勢 | ||||||||||||||||||||||||||||
掲載範囲 |
| ||||||||||||||||||||||||||||
官方網站 | http://ard.bmj.com/ | ||||||||||||||||||||||||||||
在線稿件提交 | https://mc.manuscriptcentral.com/ard | ||||||||||||||||||||||||||||
開放訪問 | No | ||||||||||||||||||||||||||||
出版商 | BMJ Publishing Group | ||||||||||||||||||||||||||||
主題領域 | 医学 | ||||||||||||||||||||||||||||
出版國/地區 | ENGLAND | ||||||||||||||||||||||||||||
發行頻率 | 月刊 | ||||||||||||||||||||||||||||
創刊年 | 1939 | ||||||||||||||||||||||||||||
每年文章數 | 148每年文章數趨勢 | ||||||||||||||||||||||||||||
黃金OA百分比 | 45.23% | ||||||||||||||||||||||||||||
Web of Science 四分位 ( 2023-2024) | WOS Quartile: Q1
| ||||||||||||||||||||||||||||
索引 (SCI or SCIE) | Science Citation Index Science Citation Index Expanded | ||||||||||||||||||||||||||||
鏈接到PubMed Central (PMC) | https://www.ncbi.nlm.nih.gov/nlmcatalog?term=0003-4967%5BISSN%5D | ||||||||||||||||||||||||||||
平均審稿時間 * | 來自出版商的數據: 來自作者的數據: Average 1.4 Month(s) | ||||||||||||||||||||||||||||
競爭力 * | 來自作者的數據: About 25% | ||||||||||||||||||||||||||||
參考鏈接 |
| ||||||||||||||||||||||||||||
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。 |
|
|
首頁 上一頁 1 2 下一頁 末頁 (頁 | |
[ANNALS OF THE RHEUMATIC DISEASES] 的評論 | 撰寫評論 |
作者: 苍风乐岚 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-03-09 18:40:24 評論於 What if it changes back to "Awaiting AE Assignment" after "Awaiting Second Opinion Comments"?(0) 讚! | 苍风乐岚 |
作者: Moon 領域: 生物学 審稿時間: 3.0 month(s) 結果: 修改後接受 撰寫評論 |
2022-09-05 15:51:29 評論於 Authoritative magazine Very difficult High requirements for innovation and clinical significance(1) 讚! | Moon |
作者: 莎乐美爱德华 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-03-24 23:26:10 評論於 About 3-5 days(0) 讚! | 莎乐美爱德华 |
作者: 莎乐美爱德华 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-03-24 10:00:56 評論於 If sent for external review later, it will be peer review in progress(0) 讚! | 莎乐美爱德华 |
作者: 其英超级甜 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-02-20 23:37:10 評論於 How long after this status appeared did it show as under review?(0) 讚! | 其英超级甜 |
作者: 蒙德雪蕊 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-01-19 16:22:36 評論於 What is proof?(0) 讚! | 蒙德雪蕊 |
作者: 莎乐美爱德华 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-07 10:13:39 評論於 My post on "Awaiting Second Opinion Comments" was under review, hoping for a good outcome. I was anxious when searching for answers before, thinking it was hopeless. But since no one had replied before, I decided to leave a comment here(0) 讚! | 莎乐美爱德华 |
作者: 昂杰来了 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-05 16:33:57 評論於 How long has a great god, awaiting second opinion comments, lasted?(0) 讚! | 昂杰来了 |
作者: 昂杰来了 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-01 16:29:13 評論於 Bro, what states have you been through?(0) 讚! | 昂杰来了 |
作者: 昂杰来了 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-11-27 23:14:26 評論於 Hey man, what happened to you later?(0) 讚! | 昂杰来了 |
作者: 香灵少爷 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-09-17 18:12:09 評論於 Review speed: 1.0 | Submission hit rate: 5.0 Experience sharing: I submitted my paper a little after ten o'clock in the morning on the first day, and I received a rejection letter the next day at nine o'clock in the morning, desk reject. This is my first time submitting to a SCI journal, really don't be too happy!!!(0) 讚! | 香灵少爷 |
作者: 是你的友竹呀 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-08-09 22:27:36 評論於 What was the situation like afterwards?(0) 讚! | 是你的友竹呀 |
作者: Myrna Milton 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-07-07 13:13:44 評論於 Oh great one, please accept my worship(0) 讚! | Myrna Milton |
作者: 筑阳冷玉 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-01-17 15:51:27 評論於 Review speed: 1.0 | Submission acceptance rate: 95.0 Experience sharing: Have published two communication articles(0) 讚! | 筑阳冷玉 |
作者: Eartha Norris 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2020-07-09 23:09:15 評論於 Review Speed: 1.0 Research Focus: Immune Experience Sharing Submitted a communication, received a reply within a week, accepted without revisions, waiting for proof, very fast speed(0) 讚! | Eartha Norris |
作者: 小志鹏吖 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2020-03-21 23:17:40 評論於 Does this magazine accept review articles? How fast is the review process?(0) 讚! | 小志鹏吖 |
作者: Rosemary Faraday 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2019-11-27 18:53:25 評論於 Have you submitted, great one? 150****7505 (No pseudonym) Posted on 2018-01-22: I'd like to ask all you experts, does the journal Case Report accept submissions?(0) 讚! | Rosemary Faraday |
作者: Oliver Jerry 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2019-10-25 08:31:57 評論於 I don't know(0) 讚! | Oliver Jerry |
作者: 凯伦福克斯 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2019-09-04 18:21:35 評論於 The review speed, online speed, and founding speed are all very fast, with the first review generally completed within a month. It does not choose OA, does not require page charges, and does not charge for color images. The journal is very rigorous and demands high innovation(0) 讚! | 凯伦福克斯 |
作者: 凯伦福克斯 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2019-02-01 14:06:28 評論於 I have submitted three papers so far. The first two were rejected within three days without external review. The third one was sent for external review in four days, which took exactly one month. With feedback from three reviewers recommending major revisions, I have now resubmitted it. As the new year begins, I hope for a positive outcome(0) 讚! | 凯伦福克斯 |
作者: 凯伦福克斯 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2019-01-29 09:33:57 評論於 I have submitted three articles so far. The first two were rejected in about 3 days without external review. The third one was sent for external review in 4 days. It took exactly one month, with three reviewers suggesting major revisions. I have now resubmitted the article and hope for a positive outcome in the new year(0) 讚! | 凯伦福克斯 |
作者: Erica Locke 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2018-01-22 08:40:48 評論於 Can you tell me if this journal accepts case reports?(0) 讚! | Erica Locke |
作者: 东海兴海 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2017-04-11 13:56:42 評論於 Multiple Submissions(0) 讚! | 东海兴海 |
作者: 风见初阳 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2017-02-21 09:01:42 評論於 What is the status of your article next?(0) 讚! | 风见初阳 |
作者: 松风雨凝 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2016-12-14 11:47:15 評論於 Review Speed: 1.0 | Submission Hit Rate: 25.0 Experience sharing: The official journal of the European League Against Rheumatism, ranks first in the field, covering all aspects of rheumatology, including musculoskeletal, arthritis, and connective tissue diseases, and related basic, clinical, and translational research. Acceptance Rate: 12% (original research articles) Publication Speed: Submission to initial decision: average 17 days (original research articles) Acceptance to publication: average 13 days (online publication(0) 讚! | 松风雨凝 |
首頁 上一頁 1 2 下一頁 末頁 (頁 |
Contact us